Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹77.5 Cr 23.9% 11.1% -39.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,389.1 Cr 2.8% 2.8% -6.6% Stock Analytics
KIRI INDUSTRIES ₹2,803.1 Cr -5.1% -12.8% -29% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,562.8 Cr -2.1% -2.4% -35.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,130.5 Cr 5.6% 4.7% 17.3% Stock Analytics
BODAL CHEMICALS ₹644.6 Cr 2.4% 2.2% -20.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

23.9%

11.1%

-39.9%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses